HIT earnings: next report 2026-07-27, real EPS beat/miss history, P/E -59.16. Updated 2026-07-23.
Health In Tech (HIT) Research Hub
Health In Tech (HIT) trades on NASDAQ, US in the Technology (Software - Application) sector. As of 2026-09-11, shares last closed at 0.9057 USD (-3.29%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -59.16, market cap 0.06B. This hub links to the full technical, earnings and options research available for HIT.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Technology (Software - Application) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 0.9057 USD (-3.29%) |
| 52-week range | 0.89 USD – 1.2 USD |
| Trend regime | Range |
| 14-day RSI | 20.9 (Oversold) |
| Trailing P/E | -59.16 |
| Market cap | 0.06B |
| Dividend yield | 0.00% |
| Next earnings | 2026-07-27 |
Available research for HIT
Covered Call on HIT: how it works, illustrative setup around the real 0.9057 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on HIT: how it works, illustrative setup around the real 0.9057 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on HIT: how it works, illustrative setup around the real 0.9057 USD price, max profit/loss, breakeven and when to use it. Educational.
HIT technical analysis: range, last 0.9057 USD, RSI 20.9, 52w range 0.89 USD–1.2 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is HIT in?
Health In Tech (HIT) is classified under Technology (Software - Application), listed on NASDAQ, US.
Is HIT in an uptrend or downtrend?
As of 2026-09-11, HIT is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is HIT's trailing P/E ratio?
HIT's trailing P/E is -59.16, with a market cap of 0.06B. See the earnings research page for full valuation detail.
When does HIT next report earnings?
HIT is next scheduled to report earnings on 2026-07-27, with a consensus EPS estimate of -0.03 USD.